Killing of Streptococcus pneumoniae by capsular polysaccharide-specific polymeric IgA, complement, and phagocytes.
about
Modulation of the lung inflammatory response to serotype 8 pneumococcal infection by a human immunoglobulin m monoclonal antibody to serotype 8 capsular polysaccharide.A molecular mucosal adjuvant to enhance immunity against pneumococcal infection in the elderlyIntranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection.Changes in the mannan binding lectin (MBL) concentration in human milk during lactation.Comparison of a classical phagocytosis assay and a flow cytometry assay for assessment of the phagocytic capacity of sera from adults vaccinated with a pneumococcal conjugate vaccine.Enhancement of protective efficacy following intranasal immunization with vaccine plus a nontoxic LTK63 mutant delivered with nanoparticlesLactococcus lactis as an adjuvant and delivery vehicle of antigens against pneumococcal respiratory infectionsAntibody-enhanced pneumococcal adherence requires IgA1 protease.Trojan horse effect: phagocyte-mediated Streptococcus iniae infection of fishPneumococcal serotype 19F conjugate vaccine induces cross-protective immunity to serotype 19A in a murine pneumococcal pneumonia model.Modulation of polymorphonuclear cell interleukin-8 secretion by human monoclonal antibodies to type 8 pneumococcal capsular polysaccharideMucosal immunology of vaccines against pathogenic nasopharyngeal bacteria.Pneumococcal IgA1 protease subverts specific protection by human IgA1On the intersections of basic and applied research in xenotransplantation.Impact of the molecular form of immunoglobulin A on functional activity in defense against Streptococcus pneumoniaeFusion proteins containing family 1 and family 2 PspA fragments elicit protection against Streptococcus pneumoniae that correlates with antibody-mediated enhancement of complement deposition.Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mousePspK of Streptococcus pneumoniae increases adherence to epithelial cells and enhances nasopharyngeal colonizationNanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques.Decreased IgA+ B cells population and IgA, IgG, IgM contents of the cecal tonsil induced by dietary high fluorine in broilers.PspA family fusion proteins delivered by attenuated Salmonella enterica serovar Typhimurium extend and enhance protection against Streptococcus pneumoniaeA novel role for plasmin-mediated degradation of opsonizing antibody in the evasion of host immunity by virulent, but not attenuated, Francisella tularensis.Polysaccharide-Specific Memory B Cells Predict Protection against Experimental Human Pneumococcal CarriageDiverse evolutionary patterns of pneumococcal antigens identified by pangenome-wide immunological screening.Mucosal adjuvants for vaccines to control upper respiratory infections in the elderly.Structure and function relationships in IgA.Immune ageing and susceptibility to Streptococcus pneumoniae.Clinical Use and Therapeutic Potential of IVIG/SCIG, Plasma-Derived IgA or IgM, and Other Alternative Immunoglobulin Preparations.Role of Streptococcus pneumoniae Proteins in Evasion of Complement-Mediated Immunity.Fine Mapping Implicates a Deletion of CFHR1 and CFHR3 in Protection from IgA Nephropathy in Han Chinese.Complement-coated antibody-transfer (CCAT); serum IgA1 antibodies intercept and transport C4 and C3 fragments and preserve IgG1 deployment (PGD).Novel PCR-restriction fragment length polymorphism method for determining serotypes or serogroups of Streptococcus pneumoniae isolates.Comparative role of immunoglobulin A in protective immunity against the Bordetellae.Yoghurt accelerates the recovery of defence mechanisms against Streptococcus pneumoniae in protein-malnourished mice.Risk factors in HIV-1-infected patients developing repetitive bacterial infections: toxicological, clinical, specific antibody class responses, opsonophagocytosis and Fc(gamma) RIIa polymorphism characteristics.Protective immune responses to meningococcal C conjugate vaccine after intranasal immunization of mice with the LTK63 mutant plus chitosan or trimethyl chitosan chloride as novel delivery platform.Streptococcal IgA-binding Proteins Bind in the Cα2-Cα3 Interdomain Region and Inhibit Binding of IgA to Human CD89
P2860
Q24532019-9B12437C-322E-489D-9C28-4A51C6A42948Q28084760-829C466E-B389-4957-8DE2-4DE7B6ACFF85Q33552360-E7123242-0995-4EAF-BF60-5B979DB33548Q33962411-8E250B89-1D26-4034-9CE1-BB8D8A9B8072Q33998938-D412089E-904B-4848-9D36-C549F4FFC59EQ34130228-CF2EFC77-6124-4F9D-AF9F-27B3AA2212F6Q34568182-C5F67699-5A6D-4515-8468-19979BFB152EQ34923082-525741CD-C827-4B05-84A6-D39661822526Q34932037-A47846A5-E6D8-4590-A2AD-C4626FE6DF7FQ34935287-6409DA48-66FE-4A8D-9B6A-1BCEF9C668A9Q34940688-E7866ADF-7161-46F5-A06A-15E98123BB85Q35588006-3DC84490-D31F-4EEB-AC8F-999771F0BBD1Q35684502-F516D6B4-6411-44A7-B268-C4A64EB89CECQ35687758-265A21EE-4399-48FB-8EB4-DBB7B126AA2EQ35783761-15E91B1B-2BDE-4880-8709-EFD977CA802FQ36314000-2BE26F1A-36D4-42B8-903C-1CFA6A21660FQ36345130-1D9AA61E-FFBB-4CED-834D-A3B788C1AC73Q36506030-3ECD9165-26C4-4022-9F3A-9C53C4F3F547Q36605149-D8CD927B-E935-4475-B948-8BB45A79FFE9Q37005785-06FE583D-ABB1-466A-B989-29B530CAA8E2Q37355855-BBBB3FF6-9D97-474F-9438-7156FCCF13C7Q37356326-6AC5314C-7ABA-448F-B823-EDC82B8A0351Q37559933-288F741E-BA51-4EDF-8072-64A77A853C4BQ37598959-FBB25AC3-F883-478D-B4F4-44F6247E7051Q37706979-607DDB7D-3A99-47BF-A777-46EFFE539ACAQ37936765-2D6AF0DD-ACF8-47F9-960F-E31AE30AD9CDQ38608479-1D1BC86F-6C4A-40DC-8681-C334808C43C8Q38820288-E5A8E26A-E4E7-4FF8-8DB2-6C1C446312E0Q39164566-A8E1369F-A8AB-49BF-9574-A5C94A401FABQ39950084-8915A6BF-8A12-401D-B40A-7A77CCCDD9C4Q40706471-2437E7D3-EC53-40D5-9FC4-A575395F27EDQ42114036-E34DF7C0-A96B-406D-8AED-E66BEA069C90Q42413095-FFCF3225-5144-4774-9163-0BAE010F89FEQ43934044-409285EB-273B-4FAC-BFDE-0A214921D884Q51700461-2C4A5DD1-4C30-4DD7-9C1C-DE9EE16B937EQ54474177-BC8D3268-7D5E-4612-B6E6-589B20602607Q57212988-78F6EC0A-3F37-4FD7-A11D-6E635194A3AD
P2860
Killing of Streptococcus pneumoniae by capsular polysaccharide-specific polymeric IgA, complement, and phagocytes.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Killing of Streptococcus pneum ...... A, complement, and phagocytes.
@ast
Killing of Streptococcus pneum ...... A, complement, and phagocytes.
@en
type
label
Killing of Streptococcus pneum ...... A, complement, and phagocytes.
@ast
Killing of Streptococcus pneum ...... A, complement, and phagocytes.
@en
prefLabel
Killing of Streptococcus pneum ...... A, complement, and phagocytes.
@ast
Killing of Streptococcus pneum ...... A, complement, and phagocytes.
@en
P2093
P2860
P356
P1476
Killing of Streptococcus pneum ...... A, complement, and phagocytes.
@en
P2093
A P Dalmasso
C Fasching
E N Janoff
J B Rubins
J M Orenstein
N L Opstad
P2860
P304
P356
10.1172/JCI6310
P407
P577
1999-10-01T00:00:00Z